[The Information reported overnight](https://www.theinformation.com/) that SpaceX is preparing an IPO roadshow targeting a $1.75 trillion valuation, with the company actively pushing underwriting banks to accept fees below 0.75%, against a historical norm closer to 1% to 1.5% for deals of this size. Separate reporting flagged that [SpaceX recently warned investors about future dilution](https://techcrunch.com/), which is adding fuel to long-running rumors of an eventual Tesla merger. Each of these data points alone would be a headline. Together they reset the playbook for how the largest private tech companies engage with public markets.
The valuation itself is staggering. At $1.75 trillion, SpaceX would list above Meta and below only Apple, Microsoft, Nvidia, Alphabet, and Amazon in the global rankings. That number is built primarily on Starlink, which has become a high-margin connectivity business with millions of subscribers and a hard-to-replicate satellite constellation, plus a launch business that effectively monopolizes commercial heavy-lift capacity. Whether the public market accepts the number is a different question. Comparable space-economy listings have traded poorly, and a $1.75 trillion market cap implies revenue growth assumptions that even Starlink will struggle to validate in year one.
The fee squeeze is more strategically interesting than the valuation. Sub-0.75% underwriting fees on a deal this size still produce more than $100 million in bank revenue, so the banks will take the work. But the precedent is what matters. Once SpaceX sets the benchmark, every other top-tier private company heading to market will cite it. Anthropic, which filed confidentially for its own IPO this week, will not pay 1% if SpaceX paid 0.7%. Stripe, Databricks, Canva, and the rest of the decacorn cohort will follow. That compresses the economics of equity capital markets desks at every bulge-bracket bank and accelerates the ongoing shift of underwriting talent into private markets and direct listings. For our finance teams, the practical consequence is that public-listing costs for our own portfolio companies (and any vendors we may inherit through acquisition) just got cheaper.
The Tesla merger rumor is the speculative wildcard. SpaceX warning of future dilution is normal pre-IPO housekeeping, but in the context of Elon Musk's repeated public musings about combining his companies, every disclosure gets read through a merger lens. A combined SpaceX-Tesla entity would be one of the largest companies in the world by enterprise value and would create unprecedented concentration of voting control under a single founder. The governance implications are enough to make most institutional investors nervous, but those same investors have shown they will hold the stock anyway. For enterprise buyers, a combined entity would not change much in the short term, but it would create new questions about long-term vendor independence for anyone relying on Starlink for backhaul or Tesla for fleet electrification.
The parallel Anthropic filing is the other piece of the puzzle. Two of the most-watched private tech companies heading to public markets in the same window is the kind of event that defines a cycle. If both price well, the IPO window will reopen aggressively for AI infrastructure, defense tech, and high-growth SaaS, all categories where we have meaningful vendor exposure. If either prices poorly, the chill on late-stage venture will extend into 2027 and consolidation pressure on mid-stage vendors will intensify.
For our strategic planning, three concrete actions. First, refresh the vendor risk register to flag any pre-IPO private vendors we depend on, with explicit notes on whether their roadmap might shift post-listing. SpaceX and Anthropic are the headline names but the cohort behind them is large. Second, for any contract renewals with venture-backed vendors in H2 2026, push for ARR-tier pricing that protects us against post-IPO list price increases (Anthropic in particular is widely expected to raise token prices after listing). Third, brief the board on the likelihood that 2026 H2 will see a wave of late-stage tech IPOs, because that wave changes the talent market for senior engineers and product leaders, and we should adjust retention plans accordingly.
The bigger pattern is that private tech is dictating terms to public markets in ways that were unthinkable five years ago. Fee compression, valuation anchoring, and dual-class governance are all moving in the issuer's favor. That is good news for founders and existing investors, mixed news for public-market buyers, and a useful reminder for the rest of us that the balance of power in tech capital formation has decisively shifted away from Wall Street.
Roadshow math and the float question
A $1.75T target implies SpaceX would price above the $400B secondary tender from late 2024 by more than 4x in roughly 18 months, a re-rating that depends almost entirely on Starlink's trajectory. Management has guided Starlink toward roughly $11.8B in 2025 revenue with more than 6 million subscribers, and bankers circling the deal are reportedly modeling a 2026 run-rate near $18B once direct-to-cell and enterprise maritime contracts ramp. If the float lands at 5% to 7%, the deal still clears $85B to $120B in primary and secondary stock, which would make it the largest listing in history and roughly double the $29.4B Saudi Aramco IPO from 2019. For procurement and treasury teams, the practical signal is that index inclusion rules at S&P and MSCI will force passive flows into the name within weeks of listing, tightening the float and creating the same scarcity premium we saw post-Meta in 2012.
The sub-0.75% fee structure also has direct precedent worth naming. Aramco paid syndicate banks roughly 0.35% in gross spreads, and Alibaba's 2014 NYSE debut settled at about 1.2% on a $25B raise, both far below the 3.5% to 7% range that mid-cap issuers still pay. What is new in the SpaceX template is the explicit linkage of fee tiers to allocation discretion: lead banks reportedly accept the haircut in exchange for larger book-running credits and follow-on mandates on Starshield and Starlink spin-outs. We expect Anthropic, Stripe, and Databricks to copy that exact clause language in their own engagement letters, which means sell-side coverage budgets for late-stage private names will compress further into 2027. Vendors that depend on banking relationships for distribution, including several data and analytics providers in our stack, should be repriced accordingly at the next renewal.
